WHO declares monkeypox a global health emergency in split vote
Image: WHO head Tedros Adhanom Ghebreyesus
Nine members of the WHO’s expert committee voted against the designation, while six voted in favour
The World Health Organisation has declared the monkeypox outbreak a global health emergency, the highest level of alert issued by the agency.
The WHO confirmed that the monkeypox outbreak represents a ‘public health emergency of international concern (PHEIC)’ on Saturday. This label is designed to instigate a coordinated international response and may unlock funding to collaborate on sharing vaccines and treatments.
Members of an expert committee met on Thursday last week to discuss the designation, after deciding against the emergency label in June. The vote was split, with nine members voting against and six voting in favour. WHO head Tedros Adhanom Ghebreyesus said he acted as a tiebreaker to resolve the vote.
Speaking to reporters on Saturday, he said: ‘Although I am declaring a public health emergency of international concern, for the moment this is an outbreak that is concentrated among men who have sex with men, especially those with multiple sexual partners.’
Tedros added that the risk of monkeypox is moderate globally, except in Europe which is considered high-risk. Before this decision, the ‘global emergency’ label only applied to the coronavirus pandemic and efforts to eradicate polio.
Monkeypox is a typically mild viral infection that is endemic in parts of west and central Africa. It spreads through close contact and can be identified by flu-like symptoms, distinctive rashes and lesions on the skin. So far this year, there have been more than 16,000 cases of the disease in more than 75 countries, and five deaths in Africa.
There has been a sharp increase in cases over the summer months in Europe.
For a full rundown on the vaccines and therapeutics available to combat the disease, read our recent article: Vaccine industry must help fight monkeypox and secure supply chains.
Related News
-
News Swiss pharma industry warns US tariffs could harm global patient care
The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.
-
News Women in Pharma: Bridging Science, Strategy, and Equity in Chemicals and Pharma
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News CPHI Podcast Series: Pharmapack special – Delivering innovation for patient outcomes
This special Pharmapack episode of our podcast, recorded live at Pharmapack 2026, interviews Terence O’Hagan, Vice President of Business Development for Drug Delivery Systems at Stevanato Group, sharing exclusive insights into the company’s... -
News Where Pharma Innovation Takes the Spotlight: Pharmapack Awards 2026
The 2026 Pharmapack Awards, held January 21, 2026, celebrated and recognised leading companies in the pharmaceutical packaging sector paving the way for packaging and drug delivery excellence in the future.
-
News Pharmapack 2026 - From the Floor
Celebrating its 25th anniversary in the city where it all started, Pharmapack 2026 is back in Paris! From January 21-22, 2026, Paris Expo Porte de Versailles opens its doors again to the pharmaceutical packaging and drug delivery sectors, ready for 2 d... -
News Driving Sustainability with Citeo PRO: An Exclusive Interview
Citeo PRO is transforming professional packaging with innovative solutions, collective action, and a dedication to sustainability within the pharmaceutical sector. Discover how they are supporting companies at Pharmapack 2026 in this interview with Dom... -
News Pharmapack's Silver Jubilee: Celebrating 25 Years of Packaging Innovation
For 25 years, Pharmapack has been at the forefront of innovation, collaboration, and progress in the pharmaceutical packaging and drug delivery industry. From its humble beginnings to becoming a global hub for industry leaders, the event has witnessed ... -
News Shaping the future of self-injection: Ypsomed's innovations at Pharmapack's 25th anniversary
Pharmapack 2026 marks a significant milestone as it celebrates its 25th anniversary, bringing together global leaders in pharmaceutical packaging and drug delivery. In this exclusive interview, Ypsomed, a pioneering developer and manufacturer of subcut...